Company / Return on Equity (ROE)
ORAGENICS INC Return on Equity (ROE) History
FY2013-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-109.8%
FY2023
5-year range
-109.8% / -47.5%
FY2019-FY2023
Trend
-85.1%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
ORAGENICS INC reports negative total equity of -109.8% in FY2023. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-109.8% in FY2023 with a 10-year CAGR of +32.0%.
Declined from -59.3% to -109.8% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -62.4pp
- 10-Year Change
- +32.0pp
Key checks
Key Insights
- In FY2023, return on equity (roe) decreased 85.1% year-over-year.
- Peak return on equity (roe) was recorded in FY2018.
- Lowest return on equity (roe) in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -147.03 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | -109.8% | -85.1% |
| FY2022 | -59.3% | +0.0% |
| FY2021 | -59.3% | -24.9% |
| FY2018 | -47.5% | +79.9% |
| FY2017 | -236.5% | +4.5% |
| FY2016 | -247.5% | -342.0% |
| FY2015 | -56.0% | +0.0% |
| FY2014 | -56.0% | +60.5% |
| FY2013 | -141.8% | +0.0% |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026